GlassScriptPhysician profile
Rohin Vij
NPI 1912439993
$5,603.58
in general payments reported to CMS, 2019-2025
17 companies · $803 in 2025
The $803 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $46.02 · 2022: $89.58 · 2023: $3,112 · 2024: $1,553 · 2025: $803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,553 · Travel and Lodging: $1,915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,553.06 |
| Travel and Lodging | $1,914.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $2,777.70 | 2022-2024 | |
| Abbvie INC. | $580.98 | 2022-2025 | Lumigan, Vuity, Xen Glaucoma Treatment System |
| Alcon Vision LLC | $547.43 | 2022-2025 | Clareon, Rocklatan, Argos |
| Tarsus Pharmaceuticals, INC. | $499.48 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $348.89 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Bausch & Lomb Americas INC. | $287.40 | 2023-2025 | Envista Mx60 Iol, Envista Aspire Iol, Miebo |
| Dompe US, INC. | $114.83 | 2024-2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $92.80 | 2024-2025 | Tecnis Iol |
| Harrow Eye, LLC | $81.86 | 2024-2025 | Vevye, Iheezo |
| Rayner Intraocular Lenses Limited | $39.03 | 2023 | Omidria, Rayone Aspheric, Rayone Emv |
| Novartis Pharmaceuticals Corporation | $38.56 | 2022-2023 | |
| Sun Pharmaceutical Industries INC. | $37.31 | 2025 | |
| Ocular Therapeutix, INC. | $28.89 | 2024-2025 | Dextenza |
| Thea Pharma INC. | $21.67 | 2025 | Iyuzeh |
| New World Medical,INC. | $20.65 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $20.16 | 2025 | Purified Cortrophin Gel |
| Eyevance Pharmaceuticals LLC | $19.92 | 2023 | Flarex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohin Vij listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.